- Home
- RPRX vs THC Comparison
RPRX vs THC Comparison
Compare RPRX & THC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- THC
- Stock Information
- Founded
- RPRX 1996
- THC 1967
- Country
- RPRX United States
- THC United States
- Employees
- RPRX N/A
- THC N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- THC Hospital/Nursing Management
- Sector
- RPRX Health Care
- THC Health Care
- Exchange
- RPRX Nasdaq
- THC Nasdaq
- Market Cap
- RPRX 16.2B
- THC 17.7B
- IPO Year
- RPRX 2020
- THC N/A
- Fundamental
- Price
- RPRX $40.42
- THC $208.62
- Analyst Decision
- RPRX Strong Buy
- THC Buy
- Analyst Count
- RPRX 3
- THC 19
- Target Price
- RPRX $46.00
- THC $217.89
- AVG Volume (30 Days)
- RPRX 2.8M
- THC 1.1M
- Earning Date
- RPRX 11-05-2025
- THC 10-28-2025
- Dividend Yield
- RPRX 2.18%
- THC N/A
- EPS Growth
- RPRX N/A
- THC N/A
- EPS
- RPRX 1.77
- THC 14.57
- Revenue
- RPRX $2,349,553,000.00
- THC $20,846,000,000.00
- Revenue This Year
- RPRX $36.16
- THC $3.67
- Revenue Next Year
- RPRX $2.04
- THC $4.52
- P/E Ratio
- RPRX $22.85
- THC $14.32
- Revenue Growth
- RPRX 3.69
- THC N/A
- 52 Week Low
- RPRX $24.05
- THC $109.82
- 52 Week High
- RPRX $41.00
- THC $217.43
- Technical
- Relative Strength Index (RSI)
- RPRX 74.39
- THC 56.85
- Support Level
- RPRX $35.92
- THC $198.33
- Resistance Level
- RPRX $37.40
- THC $209.64
- Average True Range (ATR)
- RPRX 1.09
- THC 6.88
- MACD
- RPRX 0.26
- THC -0.29
- Stochastic Oscillator
- RPRX 91.94
- THC 58.52
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About THC Tenet Healthcare Corporation
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.